Xencor to Present at Upcoming Investor Conferences

About this update from Xencor, Inc.

PASADENA, Calif. --(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced that company management will participate at multiple upcoming investor conferences: TD Cowen 44th Annual Health Care Conference Date: Wednesday, March 6, 2024 Presentation Time: 12:50 p.m. ET / 9:50 a.m. PT Location: Boston Leerink Partners Global Biopharma Conference Date: Tuesday, March 12, 2024 Presentation Date/Time: Wednesday, March 13, 2024 , 9:20 a.m. ET / 6:20 a.m. PT Location: Miami Jefferies Biotech on the Bay Summit Date: Wednesday, March 13, 2024 Location: Miami Barclays Global Healthcare Conference Date: Thursday, March 14, 2024 Presentation Time: 11:15 a.m. ET / 8:15 a.m. PT Location: Miami Live webcasts of the Cowen, Leerink and Barclays presentations will be available under “Events & Presentations” in the Investors section of the Company’s website located at www.xencor.com . Replays of the events will be available on the Xencor website for at least 30 days following the presentations. About Xencor Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20240228121602/en/ Charles Liles [email protected] (626) 737-8118 Source: Xencor, Inc.

View stock analysis, news, and events for Xencor, Inc.